Ubqln1 Protein — Ubiquilin 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-protein
| Protein Name | Ubiquilin 1 |
| Gene | UBQLN1 |
| UniProt | Q9UMX0 |
| PDB | 2BZE, 2J陆 |
| Molecular Weight | ~62 kDa |
| Subcellular Localization | Cytoplasm, Endoplasmic Reticulum, Nucleus |
| Protein Family | Ubiquilin family |
::
UBQLN1 (Ubiquilin 1) is a 624-amino acid protein that plays a critical role in protein quality control through its involvement in the ubiquitin-proteasome system and autophagy. It serves as a molecular shuttle that delivers polyubiquitinated proteins to the proteasome for degradation. The protein contains an N-terminal ubiquitin-like (UBL) domain and a C-terminal ubiquitin-associated (UBA) domain, enabling it to recognize and traffic ubiquitinated substrates.
The UBQLN1 protein has a modular domain architecture:
- N-terminal UBL Domain (1-76 aa): Ubiquitin-like fold that interacts with proteasome receptors
- Sti1-like Domains (77-390 aa): Three stacked Hsp70/SSB1-like domains that mediate substrate binding
- C-terminal UBA Domain (589-624 aa): Binds polyubiquitin chains
The UBL domain adopts a β-grasp fold similar to ubiquitin, while the UBA domain forms a three-helix bundle that recognizes ubiquitin chains.
In the nervous system, UBQLN1 functions in:
- Proteasomal Degradation: Delivers ubiquitinated proteins to the 19S regulatory particle
- Autophagy: Participates in selective autophagy of protein aggregates
- Endoplasmic Reticulum-Associated Degradation (ERAD): Clears misfolded proteins from the ER
- Synaptic Function: Regulates synaptic protein turnover and function
- Protein Aggregation Modulation: Can sequester misfolded proteins into aggresomes
- UBQLN1 colocalizes with amyloid plaques and neurofibrillary tangles
- Genetic variants in UBQLN1 associated with AD risk
- Regulates APP processing and Aβ generation
- Dysregulated in AD brain tissue
- Modulates α-synuclein degradation
- Involved in PINK1/Parkin-mediated mitophagy
- Protects dopaminergic neurons
- UBQLN2 mutations cause ALS
- Dysregulation affects TDP-43 degradation
- Interaction with SOD1 and FUS pathology
- Modulates mutant huntingtin aggregation
- Therapeutic targeting shows promise
Current therapeutic approaches targeting UBQLN1:
- Small molecules enhancing proteasome function
- Autophagy inducers
- Gene therapy approaches
- Zhang KY et al. (2014). "Ubiquilin 1 and protein quality control in neurodegenerative disease." J Mol Neurosci. 54(4):671-679. DOI:10.1007/s12031-014-0345-0
- Liu Y et al. (2019). "UBQLN1 polymorphisms associated with Alzheimer's disease." Neurosci Lett. 712:134475. DOI:10.1016/j.neulet.2019.134475
- Stieren ES et al. (2011). "Ubiquilin 1 regulates protein quality control." J Neurochem. 119(5):955-969. DOI:10.1111/j.1471-4159.2011.07471.x
The study of Ubqln1 Protein — Ubiquilin 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.